PDF herunterladen
CC BY-NC-ND 4.0 · Geburtshilfe Frauenheilkd 2020; 80(12): 1221-1228
DOI: 10.1055/a-1120-0138
GebFra Science
Review/Übersicht

Pelvic Lymphadenectomy in Vulvar Cancer – Does it make sense?

Artikel in mehreren Sprachen: English | deutsch
Linn Woelber
1   Department of Gynecology and Gynecologic Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
,
Mareike Bommert
2   Department of Gynecology and Gynecologic Oncology Kliniken Essen-Mitte, Essen, Germany
,
Katharina Prieske
1   Department of Gynecology and Gynecologic Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
28   Mildred Scheel Cancer Career Center HaTriCS4, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
,
Inger Fischer
1   Department of Gynecology and Gynecologic Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
,
Christine zu Eulenburg
3   Department of Epidemiology, UMCG, Universität Groningen, Groningen, Netherlands
,
Eik Vettorazzi
4   Department of Medical Biometry and Epidemiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
,
Philipp Harter
2   Department of Gynecology and Gynecologic Oncology Kliniken Essen-Mitte, Essen, Germany
,
Julia Jueckstock
5   Department of Gynecology and Obstetrics, University Hospital, LMU-University of Munich, Munich, Germany
,
Felix Hilpert
6   Oncologic Medical Center at the Jerusalem Hospital Hamburg, Hamburg, Germany
,
Niko de Gregorio
7   Department of Obstetrics and Gynecology, University of Ulm Medical Center, Ulm, Germany
,
Severine Iborra
8   Gynecology and Gynecologic Oncology, Uniklinik RWTH Aachen, Aachen, Germany
,
Jalid Sehouli
9   Department of Gynecology, Charité University Medicine Berlin, Campus Virchow, Berlin, Germany
,
Atanas Ignatov
10   Department of Obstetrics and Gynecology, University Hospital Magdeburg, Magdeburg, Germany
,
Peter Hillemanns
11   Department of Obstetrics and Gynecology, Hannover Medical School, Hannover, Germany
,
Sophie Fuerst
5   Department of Gynecology and Obstetrics, University Hospital, LMU-University of Munich, Munich, Germany
,
Hans-Georg Strauss
12   Department of Gynecology, University Hospital Halle, Halle, Germany
,
Klaus Baumann
13   Department of Gynecology, Medical Center Ludwigshafen, Ludwigshafen, Germany
,
Matthias Beckmann
14   Department of Gynecology and Obstetrics, University Hospital Erlangen, Comprehensive Cancer Center Erlangen-EMN, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany
,
Alexander Mustea
15   Department of Gynecology and Gynecologic Oncology, University Medical Center Bonn, Bonn, Germany
,
Werner Meier
16   Department of Obstetrics and Gynecology, Evangelical Hospital Düsseldorf, Düsseldorf, Germany
,
Pauline Wimberger
17   Department of Gynecology and Obstetrics, University Hospital Dresden, TU Dresden, Dresden, Germany
,
Lars Hanker
18   Department of Gynecology and Gynecologic Oncology, University Medical Center Lübeck, Lübeck, Germany
,
Ulrich Canzler
17   Department of Gynecology and Obstetrics, University Hospital Dresden, TU Dresden, Dresden, Germany
,
Tanja Fehm
19   Department of Gynecology and Obstetrics, University Hospital Düsseldorf, Düsseldorf, Germany
,
Alexander Luyten
20   Department of Gynecology and Obstetrics, Medical Center Wolfsburg, Wolfsburg, Germany
,
Martin Hellriegel
21   Department of Gynecology and Gynecologic Oncology, University Medical Center Göttingen, Göttingen, Germany
,
Jens Kosse
22   Department of Gynecology and Obstetrics, Sana Klinikum Offenbach, Offenbach, Germany
,
Christoph Heiss
23   Department of Gynecology, Medical Center am Eichert, Alb Fils Clinic, Klinik am Eichert, Göppingen, Germany
,
Peer Hantschmann
24   Department of Gynecology and Obstetrics, Medical Center Altötting, Altötting, Germany
,
Peter Mallmann
25   Department of Gynecology and Gynecologic Oncology, University Medical Center Köln, Köln, Germany
,
Berno Tanner
26   Department of Gynecology and Obstetrics, Medical Center Oranienburg, Oranienburg, Germany
,
Jacobus Pfisterer
27   Gynecologic Oncology Center Kiel, Kiel, Germany
,
Sven Mahner
5   Department of Gynecology and Obstetrics, University Hospital, LMU-University of Munich, Munich, Germany
,
Barbara Schmalfeldt
1   Department of Gynecology and Gynecologic Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
,
Anna Jaeger
1   Department of Gynecology and Gynecologic Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
› Institutsangaben
› Weitere Informationen
Auch verfügbar auf
   Lizenzen und Reprints

Abstract

Since the publication of the updated German guideline in 2015, the recommendations for performing pelvic lymphadenectomy (LAE) in patients with vulvar cancer (VSCC) have changed considerably. The guideline recommends surgical lymph node staging in all patients with a higher risk of pelvic lymph node involvement. However, the current data do not allow the population at risk to be clearly defined, therefore, the indication for pelvic lymphadenectomy is still not clear. There are currently two published German patient populations who had pelvic LAE which can be used to investigate both the prognostic effect of histologically verified pelvic lymph node metastasis and the relation between inguinal and pelvic lymph node involvement. A total of 1618 patients with primary FIGO stage ≥ IB VSCC were included in the multicenter AGO CaRE-1 study (1998 – 2008), 70 of whom underwent pelvic LAE. During a retrospective single-center evaluation carried out at the University Medical Center Hamburg-Eppendorf (UKE), a total of 514 patients with primary VSCC treated between 1996 – 2018 were evaluated, 21 of whom underwent pelvic LAE. In both cohorts, around 80% of the patients who underwent pelvic LAE were inguinally node-positive, with a median number of three affected groin lymph nodes. There were no cases of pelvic lymph node metastasis without inguinal lymph node metastasis in either of the two cohorts. Between 33 – 35% of the inguinal node-positive patients also had pelvic lymph node metastasis; the median number of affected groin lymph nodes in these patients was high (> 4), and the maximum median diameter of the largest inguinal metastasis was > 40 mm in both cohorts. Pelvic lymph node staging and pelvic radiotherapy is therefore probably not necessary for the majority of node-positive patients with VSCC, as the relevant risk of pelvic lymph node involvement was primarily found in node-positive patients with high-grade disease. More, ideally prospective data collections are necessary to validate the relation between inguinal and pelvic lymph node involvement.

Key words

vulvar cancer - lymph node metastasis - pelvic lymphadenectomy - recurrence - prognosis


Publikationsverlauf

Eingereicht: 09. Juli 2020

Angenommen nach Revision: 12. Oktober 2020

Artikel online veröffentlicht:
03. Dezember 2020

© 2020. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commecial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • References/Literatur

  • 1 Robert Koch-Institut. Krebs in Deutschland. 2019 Accessed April 13, 2020 at: https://www.krebsdaten.de/Krebs/DE/Content/Publikationen/Krebs_in_Deutschland/kid_2019/kid_2019_c51_vulva.pdf?__blob=publicationFile
    PubMedGoogle Scholar
  • 2 Hampl M, Deckers-Figiel S, Hampl JA. et al. New aspects of vulvar cancer: changes in localization and age of onset. Gynecol Oncol 2008; 109: 340-345
    CrossrefPubMedGoogle Scholar
  • 3 Klemm P, Marnitz S, Köhler C. et al. Clinical implication of laparoscopic pelvic lymphadenectomy in patients with vulvar cancer and positive groin nodes. Gynecol Oncol 2005; 99: 101-105
    CrossrefPubMedGoogle Scholar
  • 4 Homesley HD, Bundy BN, Sedlis A. et al. Radiation therapy versus pelvic node resection for carcinoma of the vulva with positive groin nodes. Obstet Gynecol 1986; 68: 733-740
    PubMedGoogle Scholar
  • 5 Mahner S, Jueckstock J, Hilpert F. et al. AGO-CaRE 1 investigators. Adjuvant therapy in lymph node-positive vulvar cancer: the AGO-CaRE-1 study. J Natl Cancer Inst 2015; 107: dju426
    CrossrefPubMedGoogle Scholar
  • 6 Papadia A, Ehm L, Gasparri ML. et al. Unilateral versus bilateral lymph-nodal metastases and oncologic outcome in vulvar cancer patients. J Cancer Res Clin Oncol 2020; 146: 1877-1881
    CrossrefPubMedGoogle Scholar
  • 7 Woelber L, Eulenburg C, Choschzick M. et al. Prognostic Role of Lymph Node Metastases in Vulvar Cancer and Implications for Adjuvant Treatment. Int J Gynecol Cancer 2012; 22: 503-508
    CrossrefPubMedGoogle Scholar
  • 8 Boyce J, Fruchter RG, Kasambilides E. et al. Prognostic factors in carcinoma of the vulva. Gynecol Oncol 1985; 20: 364-377
    CrossrefPubMedGoogle Scholar
  • 9 Hacker NF, Van der Velden J. Conservative management of early vulvar cancer. Cancer 1993; 71 (4 Suppl.): 1673-1677
    CrossrefPubMedGoogle Scholar
  • 10 van der Velden J, van Lindert AC, Lammes FB. et al. Extracapsular growth of lymph node metastases in squamous cell carcinoma of the vulva. The impact on recurrence and survival. Cancer 1995; 75: 2885-2890
    CrossrefPubMedGoogle Scholar
  • 11 Schnürch HG, Ackermann S, Alt CD. et al. National German Guideline S2k. Diagnosis, Therapy, and Follow-Up Care of Vulvar Cancer and its Precursors. AWMF Registry No. 015/059 2015. 2016 Accessed July 9, 2020 at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5066425/
    PubMedGoogle Scholar
  • 12 Hacker NF, Berek JS, Lagasse LD. et al. Management of regional lymph nodes and their prognostic influence in vulvar cancer. Obstet Gynecol 1983; 61: 408-412
    PubMedGoogle Scholar
  • 13 Curry SL, Wharton JT, Rutledge F. Positive lymph nodes in vulvar squamous carcinoma. Gynecol Oncol 1980; 9: 63-67
    CrossrefPubMedGoogle Scholar
  • 14 UICC. TNM classification of malignant tumours. New York: John Wiley & Sons; 2002
    Google Scholar
  • 15 Woelber L, Bommert M, Harter P. et al. Role pelvic lymph node resection in vulvar squamous-cell cancer (VSCC) – a subset analysis of the AGO-CaRE-1 study. submitted work, under review. 2020
    PubMedGoogle Scholar
  • 16 Homesley HD, Bundy BN, Sedlis A. et al. Prognostic Factors for Groin Node Metastasis in Squamous Cell Carcinoma of the Vulva (A Gynecologic Oncology Group Study). Gynecol Oncol 1993; 49: 279-283
    CrossrefPubMedGoogle Scholar
  • 17 Gonzalez Bosquet J, Kinney WK, Russell AH. et al. Risk of occult inguinofemoral lymph node metastasis from squamous carcinoma of the vulva. Int J Radiat Oncol Biol Phys 2003; 57: 419-424
    CrossrefPubMedGoogle Scholar
  • 18 Abang Mohammed DK, Uberoi R, de B Lopes A. et al. Inguinal Node Status by Ultrasound in Vulva Cancer. Gynecol Oncol 2000; 77: 93-96
    CrossrefPubMedGoogle Scholar
  • 19 de Gregorio N, Ebner F, Schwentner L. et al. The role of preoperative ultrasound evaluation of inguinal lymph nodes in patients with vulvar malignancy. Gynecol Oncol 2013; 131: 113-117
    CrossrefPubMedGoogle Scholar
  • 20 Hawnaur JM, Reynolds K, Wilson G. et al. Identification of Inguinal Lymph Node Metastases from Vulval Carcinoma by Magnetic Resonance Imaging: An Initial Report. Clin Radiol 2002; 57: 995-1000
    CrossrefPubMedGoogle Scholar
  • 21 Cohn DE, Dehdashti F, Gibb RK. et al. Prospective Evaluation of Positron Emission Tomography for the Detection of Groin Node Metastases from Vulvar Cancer. Gynecol Oncol 2002; 85: 179-184
    CrossrefPubMedGoogle Scholar
  • 22 Land R, Herod J, Moskovic E. et al. Routine computerized tomography scanning, groin ultrasound with or without fine needle aspiration cytology in the surgical management of primary squamous cell carcinoma of the vulva. Int J Gynecol Cancer 2006; 16: 312-317
    CrossrefPubMedGoogle Scholar
  • 23 Kataoka MY, Sala E, Baldwin P. et al. The accuracy of magnetic resonance imaging in staging of vulvar cancer: A retrospective multi-centre study. Gynecol Oncol 2010; 117: 82-87
    CrossrefPubMedGoogle Scholar
  • 24 Oonk MH, van Hemel BM, Hollema H. et al. Size of sentinel-node metastasis and chances of non-sentinel-node involvement and survival in early stage vulvar cancer: results from GROINSS-V, a multicentre observational study. Lancet Oncol 2010; 11: 646-652
    CrossrefPubMedGoogle Scholar